Craig H. Mermel, Ph.D.
Affiliations: | 2010 | Harvard University, Cambridge, MA, United States |
Area:
Genetics, Bioinformatics Biology, Biostatistics BiologyGoogle:
"Craig Mermel"Parents
Sign in to add mentorMetthew Meyerson | grad student | 2010 | Harvard | |
(The Analysis of Somatic Copy Number Alteration in Human Cancers.) |
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Nagpal K, Foote D, Tan F, et al. (2020) Development and Validation of a Deep Learning Algorithm for Gleason Grading of Prostate Cancer From Biopsy Specimens. Jama Oncology |
Wulczyn E, Steiner DF, Xu Z, et al. (2020) Deep learning-based survival prediction for multiple cancer types using histopathology images. Plos One. 15: e0233678 |
Ibrahim A, Gamble P, Jaroensri R, et al. (2019) Artificial intelligence in digital breast pathology: Techniques and applications. Breast (Edinburgh, Scotland). 49: 267-273 |
Chen PC, Gadepalli K, MacDonald R, et al. (2019) An augmented reality microscope with real-time artificial intelligence integration for cancer diagnosis. Nature Medicine |
Nagpal K, Foote D, Liu Y, et al. (2019) Development and validation of a deep learning algorithm for improving Gleason scoring of prostate cancer. Npj Digital Medicine. 2: 48 |
Kugel S, Feldman JL, Klein MA, et al. (2015) Identification of and Molecular Basis for SIRT6 Loss-of-Function Point Mutations in Cancer. Cell Reports. 13: 479-88 |
Niederst MJ, Sequist LV, Poirier JT, et al. (2015) RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer. Nature Communications. 6: 6377 |
Ahronian LG, Sennott EM, Van Allen EM, et al. (2015) Clinical Acquired Resistance to RAF Inhibitor Combinations in BRAF-Mutant Colorectal Cancer through MAPK Pathway Alterations. Cancer Discovery. 5: 358-67 |
Jaiswal S, Fontanillas P, Flannick J, et al. (2014) Age-related clonal hematopoiesis associated with adverse outcomes. The New England Journal of Medicine. 371: 2488-98 |
Rampal R, Al-Shahrour F, Abdel-Wahab O, et al. (2014) Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis. Blood. 123: e123-33 |